Kazakhstan Pharmaceuticals and Healthcare Report - Business Monitor International - Industry Reports

Kazakhstan Pharmaceuticals and Healthcare Report

Kazakhstan Pharmaceuticals and Healthcare Report - Business Monitor International - Industry Reports
Kazakhstan Pharmaceuticals and Healthcare Report
Published Oct 22, 2016
76 pages — Published Oct 22, 2016
Price US$ 1,295.00  |  Buy this Report Now

About This Report

  
Abstract:

In July ----, the Minister of Health and Social Development of Kazakhstan (MZSR) announced that the country will implement a reference pricing mechanism in order to regulate medicine pricing. Also in July ----, the MZSR announced the rollout of a trial for a simplified procedure for prescribing state guaranteed free medicines in Astana, which is hoped to be implemented throughout all regions of Kazakhstan by ---- if proven successful. ...In July ----, the Minister of Health and Social Development of Kazakhstan (MZSR) announced that the country will implement a reference pricing mechanism in order to regulate medicine pricing. Also in July ----, the MZSR announced the rollout of a trial for a simplified procedure for prescribing state guaranteed free medicines in Astana, which is hoped to be implemented throughout all regions of Kazakhstan by ---- if proven successful. In June ----, the MZSR held a seminar promoting the use of generic medicines which was attended by a number of pharmacists, doctors and healthcare workers. ...In June ----, the MZSR held a seminar promoting the use of generic medicines which was attended by a number of pharmacists, doctors and healthcare workers. In May ----, Kazakh MPs approved an agreement with Armenia allowing their pharmaceutical manufacturers to import medicine to Kazakhstan on facilitated conditions.

...BMI View: Kazakhstan s pharmaceutical market has grown significantly in the past five years thanks to impressive developments in the public healthcare system. However, in order for the government to achieve its goals on life expectancy and other key areas, the healthcare sector will need to receive increased and effective investments over the long term. ...BMI View: Kazakhstan s pharmaceutical market has grown significantly in the past five years thanks to impressive developments in the public healthcare system. However, in order for the government to achieve its goals on life expectancy and other key areas, the healthcare sector will need to receive increased and effective investments over the long term. Limited state coverage of medicines and lack of doctors currently inhibit the market. ...Limited state coverage of medicines and lack of doctors currently inhibit the market. As coverage to patients improves in the coming years, spurred on by the eventual introduction of a mandatory health insurance scheme in ----, we expect the overall market to be driven mainly by generic drug sales, although we expect patented medicines to perform well as well.

...BMI View: The implementation of a new health insurance scheme, as well as policies to stabilise medicine prices and increase accessibility of drugs, will boost pharmaceutical sales in Kazakhstan. Furthermore, the stabilisation of the tenge and improved outlook of the Kazakh economy will bolster foreign import sales. ...

  
Source:
Document ID
1756-6282
Country
Industry
Format:
PDF Adobe Acrobat
Buy Now

Business Monitor International - Industry Reports—Established in 1984, Business Monitor International is a leading online publisher of specialist business information on global emerging markets. Business Monitor's range of quarterly services covers political risk, finance, macroeconomic performance, outlook and forecast, industry sectors and the business operating environment. Each Industry Report has been researched at source, and features latest-available data covering production, sales, imports and exports; 5-year industry forecasts through end-2012; company rankings and competitive landscapes for multinational and local manufacturers and suppliers; and analysis of latest industry developments, trends and regulatory changes.

About the Author


Cite this Report

  
MLA:
Business Monitor International - Industry Reports. "Kazakhstan Pharmaceuticals and Healthcare Report" Oct 22, 2016. Alacra Store. Dec 08, 2016. <http://www.alacrastore.com/storecontent/Business-Monitor-International-Industry-Reports/Kazakhstan-Pharmaceuticals-and-Healthcare-Report-2026-292>
  
APA:
Business Monitor International - Industry Reports. (2016). Kazakhstan Pharmaceuticals and Healthcare Report Oct 22, 2016. New York, NY: Alacra Store. Retrieved Dec 08, 2016 from <http://www.alacrastore.com/storecontent/Business-Monitor-International-Industry-Reports/Kazakhstan-Pharmaceuticals-and-Healthcare-Report-2026-292>
  
US$ 1,295.00
$  £  
Have a Question?

Any questions about the report you're considering? Our Customer Service Team can help! Or visit our FAQs.

More Research

Search all our Market Research from one place.